Ribociclib Induced Photosensitive Skin Lesions
- PMID: 36776167
- PMCID: PMC9910512
- DOI: 10.4103/idoj.idoj_99_22
Ribociclib Induced Photosensitive Skin Lesions
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Costa R, Costa RB, Talamantes SM, Helenowski I, Peterson J, Kaplan J, et al. Meta-analysis of selected toxicity endpoints of CDK4/6 inhibitors: Palbociclib and ribociclib. Breast. 2017;35:1–7. - PubMed
-
- Seront E, Schmitz S, Papier M, van Maanen A, Henry S, Lonchay C, et al. Phase 1 study evaluating the association of the cyclin-dependent kinase 4/6 inhibitor ribociclib and cetuximab in recurrent/metastatic p16-negative squamous cell carcinoma of the head and neck. Front Oncol. 2019;9:155. - PMC - PubMed
-
- Pinard J, Patel M, Granter SR, Vleugels RA, Merola JF. Subacute cutaneous lupus erythematosus induced by palbociclib. J Cutan Med Surg. 2018;22:341–3. - PubMed
LinkOut - more resources
Full Text Sources
